#biotech
#biotech
[ follow ]
fromSFGATE
1 month ago$1.8 billion fund is gobbling up Bay Area biotech 'zombies' for cheap
Concentra Biosciences is rapidly acquiring struggling biotech companies, taking advantage of Bay Area firms' difficulties, including its recent purchase of Cargo Therapeutics, which faced severe setbacks this year.
Bicycling
Growth hacking
fromBusiness Insider
1 month agoHow one biotech company sold over 500,000 AI-powered health testing kits without cutting corners on science
Viome's at-home testing kits offer personalized health recommendations through RNA analysis and AI technology, aiming to transform disease detection.
European startups
fromSilicon Canals
2 months agoDutch-based Leyden Labs secures 20M from EIB
Leyden Laboratories secures €20M funding to enhance pandemic preparedness through innovative antiviral research.
The focus is on developing non-vaccine therapies for respiratory viruses, specifically a nasal spray targeting influenza.
fromThe Conversation
2 months agoIf it looks like a dire wolf, is it a dire wolf? How to define a species is a scientific and philosophical question
Colossal Biosciences claims to have restored the dire wolf, but in reality, they merely edited gray wolf genes, raising questions about species definition.
philosophy
Intellectual property law
fromIPWatchdog.com | Patents & Intellectual Property Law
2 months agoPharma Playbook: What Practitioners Can Learn from Early UPC Litigation
The Unified Patent Court (UPC) is now central to pharmaceutical patent disputes in Europe, affecting strategies for innovators and generics.
EPO oppositions significantly impact UPC proceedings, influencing both patent validity and injunctive relief.
fromSilicon Valley Journals
3 months agoA biotech company which developing therapies for orphan diseases raises $115M in funding
Glycomine's progress towards delivering the first disease-modifying therapy for a rare genetic disorder was bolstered by a $115 million Series C funding round.
Startup companies
[ Load more ]